Ending tuberculosis in Europe - resetting the course in the post-COVID-19 era
Open Access
- 23 March 2023
- journal article
- editorial
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 28 (12), 2300164
- https://doi.org/10.2807/1560-7917.es.2023.28.12.2300164
Abstract
Eurosurveillance.org is the online home of Eurosurveillance, Europe's journal on infectious disease surveillance, epidemiology, prevention and control.Keywords
This publication has 10 references indexed in Scilit:
- A One Health approach revealed the long-term role of Mycobacterium caprae as the hidden cause of human tuberculosis in a region of Spain, 2003 to 2022Eurosurveillance, 2023
- Active tuberculosis screening among the displaced population fleeing Ukraine, France, February to October 2022Eurosurveillance, 2023
- Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021Eurosurveillance, 2023
- Disease burden among Ukrainians forcibly displaced by the 2022 Russian invasionProceedings of the National Academy of Sciences of the United States of America, 2023
- Availability and costs of medicines for the treatment of tuberculosis in EuropeClinical Microbiology & Infection, 2023
- Rifapentine access in Europe: growing concerns over key tuberculosis treatment componentEuropean Respiratory Journal, 2022
- Early COVID-19 pandemic’s toll on tuberculosis services, WHO European Region, January to June 2020Eurosurveillance, 2021
- Impact of the COVID-19 pandemic on tuberculosis laboratory services in EuropeEuropean Respiratory Journal, 2020
- WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: Module 1: prevention2020
- Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statementEuropean Respiratory Journal, 2012